Taking into account the 2015 ATA guidelines that recommend target TSH levels in the range of 0.5–2 mUI/L after lobectomy for patients with thyroid cancer, however, up to 73% of patients—excluding those with thyroiditis—may need thyroid hormone supplementation [26]. Here, TG is linked to thyroid gland carcinoma.